NSAIDs Flashcards
Acetyl Salicylic Acid [Aspirin]
Salicyclic Acid Derivatives
(don’t know chemical groups)
salicylate ester of acetic acid
irreversibly acetylates/inactivates COX in platelets, megakaryocytes
(4-7 days, life of platelet)
anti-inflammatory, antithrombotic effects (inactivates platelets)
Mesalamine (5-amino salicylic acid) [Apriso®]
Salicyclic Acid Derivative
- reversible inhib COX-1 and COX-2
toxicity: GI, CNS, nasophary., hypersn
used for UC
Diflunisal
Salicyclic Acid Derivative
reversible inhib. of COX
analgesic, anti-inflammatory
little antipyretic activity
long 1/2 life (8-12 hrs), inc. pt compliance
less GI SEs, don’t use in pts with anti-ASA sn.
tox: GI (mild), ha, renal, hypersn
Indomethacin [IndocinR]
Acetic Acid Derivative
rev. inhib COX 1 and 2
tox: GI, bleeding, CV, CNS
use: RA (NOT JRA), OA, tocolytic agent
Etodolac
Acetic Acid Derivative
more COX-2 selectivity
tox: GI, less sev.
use: FA, OA, postop analgesic
Diclofenac
Acetic Acid Derivative
rev. inhib COX 1 and 2
tox: GI, CNS
use: RA, OA, anagesia/dysmenorrhea
Tolmetin
Acetic Acid Derivative
rev. inhib COX 1 and 2
tox: GI, CNS, anaphylaxis!
use: RA, JRA*, OA
Ketorolac
Acetic Acid Derivative
rev. inhib COX 1 and 2
tox: GI, CNS
use: mod sev, acute pain, NOT for RA/OA
Ibuprofen [MotrinR, AdvilR]
Propionic Acid Derivative
rev. inhib COX 1 and 2
tox: GI (less than ASA, indometh.), ocular disturbs, hypersn rash, avoid during preg/breast feeding
uses: RA, OA, analgesia, dysmenorrhea, fever
Naproxen [AnaproxR, NaprosynR, AleveR]
Propionic Acid Derivative
rev. inhib COX 1 and 2
tox: GI
Ketoprofen
Propionic Acid Derivative
rev. inhib COX 1 and 2
tox: GI, CNS
use: RHA, OA, analgesia, dysmenorrhea
Oxaprozin [DayproR]
Propionic Acid Derivative
rev. inhib COX 1 and 2
(1x/day)
tox: GI
use: RA, OA
Piroxicam (FeldeneR)
Enolic Acid Derivative: Oxicam
rev. inhib COX 1 and 2
tox: GI
use: RA, OA
Meloxicam (MobicR)
Enolic Acid Derivative: Oxicam
rev. inhib COX 2 > 1
tox: GI
use: OA
Nabumetone
Non acidic compound (Alkanones)
rev. inhib COX 2 > 1
activated by liver
tox: GI, CNS
use: RA, OA
Acetaminophen [TylenolR]
Para aminophenol derivative
weak inhibition COX-1,2,3
antipyretic by acting on hypothalamic heat-regulating center
tox: *hepatotoxicity, *nephrotoxicity, hypersn
uses: antipyretic, analgesic, OA
platelets only have..
COX-1 (not COX-2)
Celecoxib (CelebrexR)
COX-2 INHIBITOR
Acetyl Salicylic Acid [Aspirin] GI absorption mechs
more non-ionized ASA in stomach (where it’s acidic)–>can be absorbed by gastric mucosa cell
in mucosa cell: it’s ionized–>stuck there
ionized in sm. int. BUT larger surf. area so absorbed
Acetyl Salicylic Acid [Aspirin] pharmkin
widely distributed through tissues, binds plasma proteins
can diffuse through placenta and BBB–>CNS effects
Acetyl Salicylic Acid [Aspirin] metab/elim
urinary pH changes from 5 to 8 in kidneys (alkalinization with sodium bicarbonate)
*ASA in ionized state, does not diffuse back, excreted), the renal clearance of free ionized salicylate increases from 2-3% of the amount excreted to about 80%
(The opposite happens in acidic urine)
Acetyl Salicylic Acid [Aspirin] GI SEs
dyspepsia, heartburn, epigastric distress, nausea
less frequently vomiting, anorexia, abdominal pain
inc. with high doses/pre-existing ulcer
occult bleeding, gastric mucosal damage, iron def. anemia (case)
reactivate latent gastric and duodenal ulcers
*most freq. with ASA than other salicylates
case: iron def. anemia enteric-coated reg. strength ASA 1 mg warfarin INR 1.15 tablet in ulcer of gastric antrum tx w. endolcac and ASA -DON't DO: synergy
tx w. lasoprazole (PPI)
Misoprostol (Cytotec®)
prostaglandin E1 analogue
can protect stomach by lowering gastric acid production, anti ulcer with ASA tx
ASA otic effects
tinnitus and hearing loss- *reversible
200-300 μg/mL for anti-inflammatory effects, appearance of tinnitus
indicates adequate plasma concentrations have been reached
ASA hepatic effects
reversible, particularly with previous hepatic impairment and high dose salicylates
-must monitor
ASA renal effects
renal medullary ischemia as a result of inhibition of renal prostaglandin synthesis
ASA CV effects
noncardiogenic pulmonary edema, HTN
CI: CHF pts (esp. w. Na)